Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07764120
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, GrenobleNot Yet Recruiting
NCT07764120Not Yet Recruiting
—
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, Gren...
NCT07764029
Efficacy of PRF and Xenograft in Treating Mandibular Molar Furcation InvolvementsUniversity of Medicine and Pharmacy at Ho Chi Minh CityRecruitingNot Applicable
NCT07764029Recruiting
Not Applicable
Efficacy of PRF and Xenograft in Treating Mandibular Molar Furcation Involvement...University of Medicine an...
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07762196
Measuring the Effects of Music-Listening On Distress After Intensive CareNHS FifeNot Yet RecruitingNot Applicable
NCT07762196Not Yet Recruiting
Not Applicable
Measuring the Effects of Music-Listening On Distress After Intensive CareNHS Fife
NCT07764328
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms.Mila Mend Inc.RecruitingNot Applicable
NCT07764328Recruiting
Not Applicable
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Bal...Mila Mend Inc.
NCT07762612
"Gwan Enjoy Life:" A Peer-Supported Mental Health Mentoring Intervention to Improve Engagement in Care Among Sexual Minority Men Living With HIV in JamaicaNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07762612Not Yet Recruiting
Not Applicable
"Gwan Enjoy Life:" A Peer-Supported Mental Health Mentoring Intervention to Impr...National Institute of Men...
NCT07763678
Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater Auricular Nerve Block Versus Greater Occipital Nerve Block Alone in the Management of Chronic MigraineAssiut UniversityNot Yet RecruitingPhase 4
NCT07763678Not Yet Recruiting
Phase 4
Efficacy of Ultrasound-Guided Combined Greater Occipital Nerve Block and Greater...Assiut University
NCT07762729
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up StudyChildren's Hospital of Fudan UniversityEnrolling By Invitation
NCT07762729Enrolling By Invitation
—
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up...Children's Hospital of Fu...
NCT07762950
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisChanghai HospitalNot Yet Recruiting
NCT07762950Not Yet Recruiting
—
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancre...Changhai Hospital
NCT07763366
Pain Neuroscience Education and Graded Motor Imagery Combined With Conventional Physiotherapy on Diabetic Adhesive CapsulitisRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07763366Not Yet Recruiting
Not Applicable
Pain Neuroscience Education and Graded Motor Imagery Combined With Conventional...Riphah International Univ...
NCT07761988
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society, Inc.Not Yet RecruitingNot Applicable
NCT07761988Not Yet Recruiting
Not Applicable
The FamilyStrong Pilot Randomized TrialAmerican Cancer Society,...
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07763015
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals, Inc.Not Yet RecruitingPhase 2
NCT07763015Not Yet Recruiting
Phase 2
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals,...
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762235
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive ImpairmentIstinye UniversityNot Yet RecruitingNot Applicable
NCT07762235Not Yet Recruiting
Not Applicable
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive Impairme...Istinye University
NCT07763704
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut UniversityNot Yet Recruiting
NCT07763704Not Yet Recruiting
—
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy BleedingAssiut University
NCT07763132
Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blood Draws in ChildrenMarie LulkováRecruitingNot Applicable
NCT07763132Recruiting
Not Applicable
Comparison of Virtual Reality, EMLA Cream, and Standard Care for Pain During Blo...Marie Lulková
NCT07763847
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.Mst.Sumyara KhatunCompletedNot Applicable
NCT07763847Completed
Not Applicable
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Co...Mst.Sumyara Khatun
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified5 (25%)
Phase 42 (10%)
Phase 11 (5%)
Phase 21 (5%)
Phase 31 (5%)